Literature DB >> 26197201

Water and solute transport across the peritoneal membrane.

Johann Morelle1, Olivier Devuyst.   

Abstract

PURPOSE OF REVIEW: We review the molecular mechanisms of peritoneal transport and discuss how a better understanding of these mechanisms is relevant for dialysis therapy. RECENT
FINDINGS: Peritoneal dialysis involves diffusion and osmosis through the highly vascularized peritoneal membrane. Computer simulations, expression studies and functional analyses in Aqp1 knockout mice demonstrated the critical role of the water channel aquaporin-1 (AQP1) in water removal during peritoneal dialysis. Pharmacologic regulation of AQP1, either through increased expression or gating, is associated with increased water transport in rodent models of peritoneal dialysis. Water transport is impaired during acute peritonitis, despite unchanged expression of AQP1, resulting from the increased microvascular area that dissipates the osmotic gradient across the membrane. In long-term peritoneal dialysis patients, the fibrotic interstitium also impairs water transport, resulting in ultrafiltration failure. Recent data suggest that stroke and drug intoxications might benefit from peritoneal dialysis and could represent novel applications of peritoneal transport in the future.
SUMMARY: A better understanding of the regulation of osmotic water transport across the peritoneum offers novel insights into the role of water channels in microvascular endothelia, the functional importance of structural changes in the peritoneal interstitium and the transport of water and solutes across biological membranes in general.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26197201     DOI: 10.1097/MNH.0000000000000151

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  2 in total

1.  Mechanisms of Crystalloid versus Colloid Osmosis across the Peritoneal Membrane.

Authors:  Johann Morelle; Amadou Sow; Charles-André Fustin; Catherine Fillée; Elvia Garcia-Lopez; Bengt Lindholm; Eric Goffin; Fréderic Vandemaele; Bengt Rippe; Carl M Öberg; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2018-05-29       Impact factor: 10.121

2.  PPAR-γ agonist rosiglitazone ameliorates peritoneal deterioration in peritoneal dialysis rats with LPS-induced peritonitis through up-regulation of AQP-1 and ZO-1.

Authors:  Yunfang Zhang; Junxia Feng; Qi Wang; Shili Zhao; Jiaqi Xu; Hongyan Li
Journal:  Biosci Rep       Date:  2018-06-21       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.